CD274 and non-small cell lung carcinoma: While studies show that PD-L1 does not appear to be associated with the incidence of venous thromboembolism in NSCLC [41], others have found that the presence of PD-L1 in NSCLC may be associated with an increased risk of thromboembolism [42].